HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Monitoring Pc 4 photodynamic therapy in clinical trials of cutaneous T-cell lymphoma using noninvasive spectroscopy.

Abstract
Silicon phthalocyanine Pc 4 photodynamic therapy (Pc 4-PDT) has emerged as a potentially effective treatment for cutaneous T-cell lymphoma (CTCL). Noninvasive reflectance and fluorescence spectroscopy before, during, and after PDT may provide useful dose metrics and enable therapy to be tailored to individual lesions. We present the design and implementation of a portable bedside spectroscopy system for initial clinical trials of Pc 4-PDT of CTCL. Reflectance and fluorescence spectra were obtained from an early stage CTCL patient throughout the course of the PDT treatment. Preliminary patient data show a significant effect of Pc 4 on the tissue absorption, modest Pc 4 photobleaching, and heterogeneity of Pc 4 within and between the lesions.
AuthorsTammy K Lee, Elma D Baron, Thomas H Foster
JournalJournal of biomedical optics (J Biomed Opt) 2008 May-Jun Vol. 13 Issue 3 Pg. 030507 ISSN: 1083-3668 [Print] United States
PMID18601524 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Indoles
  • Organosilicon Compounds
  • silicon phthalocyanine
Topics
  • Humans
  • Indoles (therapeutic use)
  • Lymphoma, T-Cell (diagnosis, drug therapy)
  • Organosilicon Compounds (therapeutic use)
  • Photochemotherapy (methods)
  • Prognosis
  • Skin Neoplasms (diagnosis, drug therapy)
  • Spectrometry, Fluorescence (methods)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: